Recorded Chinese product: 甘油果糖注射液甘油果糖注射液
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 扬州中宝制药有限公司Chinese legal name: 扬州中宝制药有限公司
主要成分Active Ingredients
- 果糖CHOGuo Tang
- 钠NaClNa
- 注射用水适量Recorded Chinese product: 注射用水适量
- 全量毫升Quanliang Haosheng
药物知识说明
果糖CHO是一种在国家药监局注册认定的药品。该药品含有全量毫升、果糖cho、注射用水适量-461d5e49等成分。
该药品关联的活性成分包括:全量毫升Quanliang Haosheng、果糖cho、注射用水适量、钠nacl。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为:扬州中宝制药有限公司Chinese legal name: 扬州中宝制药有限公司。
您可以探索含有相同成分的其他药品:全量毫升-f669562c成分药品。
本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 甘油果糖注射液) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 全量毫升Quanliang Haosheng.
Manufacturers recorded for this product: 扬州中宝制药有限公司Chinese legal name: 扬州中宝制药有限公司.
Explore other medicines containing the same ingredient: 全量毫升 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 甘油果糖注射液Recorded Chinese product: 甘油果糖注射液
- 剂型Dosage form: 注射剂Injection
- 规格Specification: 250ml250 mL
本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 扬州中宝制药有限公司Chinese legal name: 扬州中宝制药有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H20066414
关联实体Relationships
信息来源Source and scope
国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H20066414
Manufacturer
Chinese legal name: 扬州中宝制药有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H20066414
生产企业
扬州中宝制药有限公司(国产)
适应症
本品用于脑血管病、脑外伤、脑肿瘤、颅内炎症及其他原因引起的急慢性颅内压增高,脑水肿等症。
用法用量
静脉滴注,成人一般一次250~500ml,一日1~2次,每次500ml需滴注2~3小时,250ml需滴注1~1.5小时。根据年龄、症状可适当增减。
不良反应
本品一般无不良反应,偶可出现溶血现象。
禁忌
1. 对有遗传性果糖不耐症患者禁用。2. 对严重循环系统机能障碍、尿崩症、糖尿病患者慎用。
注意事项
1. 使用前必须认真检查,如发现容器渗漏,药液混浊变色切勿使用。2. 本品含氯化钠0.9%,用药时须注意患者食盐摄入量。
贮藏
避光,密封
规格
250ml
信息来源Source and scope
国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.